TrialClinical cancer research : an official journal of the American Association for Cancer Research2017

A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma.

Marjorie G Zauderer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.